Pharmacology of second generation low molecular weight heparins

Publisher： Karger

E-ISSN： 1424-8840|32|5-6|401-402

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.5-6, 2003-08, pp. : 401-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Low-Molecular-Weight Heparins: Are They Interchangeable?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 148-157

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins in the Management of Unstable Angina

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 158-167

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins, Acenocoumarol and Bone Density

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

Comparative Inhibition of LPS-Activated Human Monocyte-Induced Thrombin Generation by Unfractionated Heparin and Low Molecular Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 6, 2000-06 ,pp. : 301-309

Karger

Access to resources Recommend Favorite

Low molecular weight heparins: the optimal treatment for venous thromboembolism

By Daskalopoulos Marios E.   Daskalopoulou Stella S.   Liapis Christos D.  

Current Medical Research and Opinion, Vol. 20, Iss. 7, 2004-07 ,pp. : 1001-1005

Informa Healthcare

Access to resources Recommend Favorite